RZLT
Rezolute, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.70
+3.35%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.18
- Revenue estimate
- $1.1M
Latest reported
- Last report date
- Sep 24, 2026
- EPS actual
- -$0.20
- EPS estimate
- -$0.15
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- -13.7%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $11
- PT range
- $7.00 – $15
- Analysts
- 5
5 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Sep 24, 2026 | -$0.15 | -$0.20 | Miss -35.27% | — |
| May 12, 2026 | -$0.14 | -$0.16 | Miss -15.47% | — |
| Feb 12, 2026 | -$0.16 | -$0.22 | Miss -37.50% | — |
| Nov 6, 2025 | -$0.27 | -$0.18 | Beat 33.33% | — |
| Sep 17, 2025 | -$0.23 | -$0.26 | Miss -13.04% | — |
| Feb 12, 2025 | -$0.33 | -$0.22 | Beat 33.33% | — |
| Nov 7, 2024 | -$0.35 | -$0.22 | Beat 37.14% | — |
| Sep 19, 2024 | -$0.30 | -$0.44 | Miss -46.67% | $58.0K |
| May 15, 2024 | -$0.34 | -$0.34 | In line | — |
| Feb 13, 2024 | -$0.27 | -$0.27 | In line | — |
| Nov 13, 2023 | -$0.33 | -$0.28 | Beat 15.15% | — |
| Sep 14, 2023 | -$0.34 | -$0.25 | Beat 26.47% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026